Stoboclo Injection
Product Images NDC 72606-037

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Stoboclo (NDC 72606-037). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Celltrion Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Stoboclo 01)

This text provides a list of components related to a medical device, possibly a syringe. It includes terms like Plunger, Rod, Finger Flange, Viewing Medicine Window, Safety Guard, Needle, and a value ".10". It may be a before and after comparison guide for using the device.*

FDA Label Image

Image (Stoboclo 02)

FDA Label Image

Image (Stoboclo 03)

FDA Label Image

Image (Stoboclo 04)

FDA Label Image

Image (Stoboclo 05)

FDA Label Image

Chemical Structure (Stoboclo 06)

This text provides information on the incidence of hip fractures in a study comparing a placebo group (N = 3906) to a Denosumab group (N = 3902). The data may be presented over a study month timeline for analysis and comparison.*

FDA Label Image

Principal Display Panel (60 mg/mL Syringe Carton)

The text provides information about a Singlo-dosa Prefilled Syringe with Safety Guard intended for subcutaneous use only. It contains no preservatives and should be administered by a healthcare provider. The solution includes various ingredients and is distributed by CELLTRION, Inc. in the Republic of Korea and the USA. The recommended dosage is once every 6 months, and a Medication Guide should be dispensed to each patient.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.